tiprankstipranks
Trending News
More News >
Oramed Pharmaceuticals (ORMP)
NASDAQ:ORMP
US Market
Advertisement

Oramed Pharm (ORMP) Income Statement

Compare
523 Followers

Oramed Pharm Income Statement

Last quarter (Q2 2025), Oramed Pharm's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Oramed Pharm's net income was $13.29M. See Oramed Pharm’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 1.34M$ 2.70M$ 2.70M$ 2.71M
Gross Profit
$ -193.00K$ 1.34M$ 2.70M$ 2.70M$ 2.62M
Operating Expenses
$ 12.78M$ 17.11M$ 43.30M$ 26.93M$ 14.47M
Depreciation and Amortization
$ 193.00K$ 196.00K$ 3.62M$ 77.00K$ 7.00K
EBITDA
$ -14.87M$ -15.57M$ -36.98M$ -25.04M$ -11.31M
Operating Income
$ -12.78M$ -15.77M$ -40.60M$ -24.22M$ -11.76M
Other Income/Expenses
$ -3.14M$ 20.86M$ 2.93M$ 893.00K$ -438.00K
Pretax Income
$ -15.92M$ 5.09M$ -37.66M$ -22.99M$ -11.51M
Net Income
$ -19.10M$ 5.53M$ -37.76M$ -22.24M$ -11.51M
Per Share Metrics
Basic EPS
$ -0.47$ 0.14$ -0.97$ -0.78$ -0.56
Diluted EPS
$ -0.47$ 0.14$ -0.97$ -0.78$ -0.56
Weighted Average Shares Outstanding
40.83M 40.32M 39.00M 28.47M 20.53M
Weighted Average Shares Outstanding (Diluted)
40.83M 40.57M 39.00M 28.47M 20.53M
Currency in USD

Oramed Pharm Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis